View in EDS

Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.

Saved in:
Bibliographic Details
Title: Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.
Authors: Forero A; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Li Y; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Chen D; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Grizzle WE; Department of Pathology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Updike KL; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah., Merz ND; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah., Downs-Kelly E; Department of Pathology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Burwell TC; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama., Vaklavas C; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Buchsbaum DJ; Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Myers RM; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama., LoBuglio AF; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Varley KE; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah.
Source: Cancer immunology research [Cancer Immunol Res] 2016 May; Vol. 4 (5), pp. 390-9. Date of Electronic Publication: 2016 Mar 15.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-15-0243